Literature DB >> 3687918

The incidence and epidemiologic characteristics of neuroblastoma in the United States.

S Davis1, M A Rogers, T W Pendergrass.   

Abstract

The incidence of neuroblastoma in the United States is described in relation to age, sex, race, and anatomic site, as well as population-derived indicators of socioeconomic levels, degree of urbanization, and farming activity. Incidence data were obtained for the years 1973-1978 from the Surveillance, Epidemiology and End Results Program of the National Cancer Institute. Based upon 265 cases, the overall incidence of neuroblastoma was 2.26 per million person-years. Approximately 60% of the cases were diagnosed under age two years, 75% under age five years and 84% under age 10 years. The incidence among males was 1.3 times that among females, but the male predominance was observed only among persons diagnosed under age five years. Although no difference in overall incidence was observed by race, the rate among whites was 1.6 times that among blacks and 1.5 times that among other nonwhites under age five years. Approximately 50% of all cases were diagnosed with tumors arising from the adrenals or soft tissues. No clear pattern of area-to-area variation in incidence was identified. Neuroblastoma incidence was inversely related to socioeconomic level as measured by per capita income (p = 0.05), as well as the proportion of county land devoted to farming (p = 0.034). No association was observed in relation to urbanization or population density.

Entities:  

Mesh:

Year:  1987        PMID: 3687918     DOI: 10.1093/oxfordjournals.aje.a114745

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  13 in total

1.  Incidence, ocular manifestations, and survival in children with neuroblastoma: a population-based study.

Authors:  Stephen J Smith; Nancy N Diehl; Brian D Smith; Brian G Mohney
Journal:  Am J Ophthalmol       Date:  2010-02-10       Impact factor: 5.258

2.  Gastrin-releasing peptide is a growth factor for human neuroblastomas.

Authors:  Sunghoon Kim; Wanqin Hu; David R Kelly; Mark R Hellmich; B Mark Evers; Dai H Chung
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

3.  Primary cerebral neuroblastoma (neurocytoma) in adults.

Authors:  E Ferreol; R Sawaya; G M de Courten-Myers
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

4.  Adult Neuroblastoma-Case Report and Literature Review.

Authors:  Vishwapriya Mahadev Godkhindi; Maheboob M Basade; Kamran Khan; Kiran Thorat
Journal:  J Clin Diagn Res       Date:  2016-12-01

5.  Reduced folate carrier-1 G80a gene polymorphism is associated with neuroblastoma's development.

Authors:  Dyego O de Miranda; Jemima E X S Barros; Maria Madalena S Vieira; Elker L S Lima; Vera L L Moraes; Helker A da Silva; Helder L B O Garcia; Cássia A Lima; Adriana V Gomes; Neide Santos; Maria T C Muniz
Journal:  Mol Biol Rep       Date:  2014-04-27       Impact factor: 2.316

Review 6.  Cancer of childhood in sub-Saharan Africa.

Authors:  Cristina Stefan; Freddie Bray; Jacques Ferlay; Biying Liu; D Maxwell Parkin
Journal:  Ecancermedicalscience       Date:  2017-07-28

7.  Review of our experience with neuroblastoma and ganglioneuroblastoma in adults.

Authors:  Nezar Y Jrebi; Corey W Iqbal; Gaëtan-Romain Joliat; Thomas J Sebo; David R Farley
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

8.  A malignant transformation of a spinal epidural mass from ganglioneuroblastoma to neuroblastoma.

Authors:  Mehmet Osman Akcakaya; Bilge Bilgic; Yavuz Aras; Nail Izgi
Journal:  J Korean Neurosurg Soc       Date:  2015-03-20

9.  Long-Term Survival in Adult Neuroblastoma with Multiple Recurrences.

Authors:  L Vénat-Bouvet; V Le Brun-Ly; J Martin; O Gasnier; S Falkowsky; N Tubiana-Mathieu
Journal:  Case Rep Oncol       Date:  2010-02-24

10.  Targeting gastrin-releasing peptide suppresses neuroblastoma progression via upregulation of PTEN signaling.

Authors:  Pritha Paul; Jingbo Qiao; Kwang Woon Kim; Carmelle Romain; Sora Lee; Natasha Volny; Bret Mobley; Hernan Correa; Dai H Chung
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.